The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures
Status:
Withdrawn
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine if the use of tranexamic acid, a safe and effective
antifibrinolytic, in patients with intertrochanteric hip fractures will result in a reduction
in blood transfusion rates. Treatment will be administered pre-operatively as well as at the
time of surgical incision. The primary outcome will be need for blood transfusion. Secondary
outcomes will include calculated perioperative blood loss, length of stay, cost of inpatient
care, and rate of adverse events, including DVT, PE, infection, MI, cerebrovascular event,
need for re-hospitalization or re-operation and 30 day mortality.